Y-Intercept (HK)’s Indivior Pharmaceuticals INDV Stock Holding History

Y-Intercept (HK)’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.61M	Buy	+136,725	New	+$4.96M	0.11%	248
2025 Q4	–	Sell	-52,007	Closed	-$1.25M	–	1752
2025 Q3	$1.25M	Buy	52,007 +26,564	+104%	+$556K	0.03%	868
2025 Q2	$375K	Buy	25,443 +3,769	+17%	+$43.9K	0.01%	1295
2025 Q1	$207K	Buy	+21,674	New	+$228K	0.01%	1045
2024 Q3	–	Sell	-20,022	Closed	-$323K	–	1542
2024 Q2	$323K	Buy	+20,022	New	+$361K	0.02%	1013

Other funds holding INDV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Y-Intercept (HK)'s INDV Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 136,725 shares worth $5.61M. The stake represents 0.11% of the portfolio and ranks #248 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in INDV as recently as Q3 2025.

Y-Intercept (HK) first reported a position in INDV in Q2 2024 and has held it in 5 quarters since. 55 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Y-Intercept (HK) held 136,725 shares of Indivior Pharmaceuticals worth $5.61M as of Q2 2026.
Indivior Pharmaceuticals was a new Y-Intercept (HK) position in Q2 2026.
Indivior Pharmaceuticals made up 0.11% of Y-Intercept (HK)'s portfolio in Q2 2026, its #248 holding.
Y-Intercept (HK) first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
55 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.